| Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive | |
|---|---|
| Approved on: | 2024-03-13 |
| Brief purpose of the study: | The purpose of the research study is to identify novel compounds that can inhibit semen liquefaction process in humans as a new contraceptive method. |
| Brief summary of what participants will be asked to do: | Provide semen sample (up to three visits). |
| Basic eligibility criteria: | A healthy male in the reproductive age (18 years or older) |
| Study contact for more information: | Dr. Joy Winuthayanon at w.winuthayanon@health.missouri.edu |
| IRB Number: | 2092048 MU |